Worried about radioactive shrimp? CFIA says no sign they were sold here
The U.S. Food and Drug Administration on Tuesday issued a warning about a frozen shrimp brand sold at some Walmart stores in the U.S. due to radioactive contamination in one shipment that was identified before it entered the country.
The FDA warning covers multiple lots of shrimp sold by distributors in the U.S.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
However, authorities in Canada told Global News that there were no reports of the affected product being sold in Canada.
'The Canadian Food Inspection Agency (CFIA) is aware of the public advisory published by the United States (U.S.) Food and Drug Administration (FDA) advising the U.S. public to not eat, sell, or serve certain imported shrimp. The CFIA is not aware of any Canadian distribution of these recalled products,' a CFIA spokesperson told Global News in an emailed statement.
Story continues below advertisement
The U.S. notice pertains to certain frozen shrimp products sold by Indonesian company PT Bahari Makmur Sejati, sold in the U.S. under the label BMS Foods.
The affected product was sold at Walmart stores in 13 U.S. states — Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Pennsylvania, Texas and West Virginia.
The U.S. FDA discovered high levels of Caesium-137 — a radioactive isotope — in a single shipment of the shrimp that did not enter the U.S.
The notice said 'exposure to low-level radiation' from the radioactive containment can cause 'an elevated risk of cancer, resulting from damage to DNA within living cells of the body.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
2 hours ago
- Global News
Worried about radioactive shrimp? CFIA says no sign they were sold here
Seafood lovers in the U.S. are being warned about a recall over the risk of potentially radioactive shrimp — and no, it's not a character in a new superhero movie. The U.S. Food and Drug Administration on Tuesday issued a warning about a frozen shrimp brand sold at some Walmart stores in the U.S. due to radioactive contamination in one shipment that was identified before it entered the country. The FDA warning covers multiple lots of shrimp sold by distributors in the U.S. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy However, authorities in Canada told Global News that there were no reports of the affected product being sold in Canada. 'The Canadian Food Inspection Agency (CFIA) is aware of the public advisory published by the United States (U.S.) Food and Drug Administration (FDA) advising the U.S. public to not eat, sell, or serve certain imported shrimp. The CFIA is not aware of any Canadian distribution of these recalled products,' a CFIA spokesperson told Global News in an emailed statement. Story continues below advertisement The U.S. notice pertains to certain frozen shrimp products sold by Indonesian company PT Bahari Makmur Sejati, sold in the U.S. under the label BMS Foods. The affected product was sold at Walmart stores in 13 U.S. states — Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Pennsylvania, Texas and West Virginia. The U.S. FDA discovered high levels of Caesium-137 — a radioactive isotope — in a single shipment of the shrimp that did not enter the U.S. The notice said 'exposure to low-level radiation' from the radioactive containment can cause 'an elevated risk of cancer, resulting from damage to DNA within living cells of the body.'
The Market Online
2 hours ago
- The Market Online
Ocumetics stock continues to climb after bionic lens implant
Shares of Ocumetics Technology (TSXV:OTC) are up by almost 400 per cent following Monday's announcement of a historical milestone: the first-in-human implant of a bionic intraocular lens Ocumetics is a Canadian research and product development company focused on vision-correction solutions Ocumetics stock has added 464.52 per cent year-over-year Shares of Ocumetics Technology (TSXV:OTC) are up by almost 400 per cent following Monday's announcement of a historical milestone: the first-in-human implant of a bionic intraocular lens. This content has been prepared as part of a partnership with Ocumetics Technology Corp., and is intended for informational purposes only. Unlike traditional monofocal or multifocal lenses, the Ocumetics Lens is designed to work with the natural movements of the eye, allowing the user to see clearly close up and at a distance without glasses or contacts following cataract surgery. The successful procedure is an important step in the drive to restore dynamic vision, with initial post-operative results expected in the coming weeks and additional implants planned under the clinical trial program over the coming months. Leadership insights 'This is a moment of immense pride for our team and everyone who has believed in Ocumetics from the beginning,' Dean Burns, Ocumetics Technology's president and chief executive officer, stated in Monday's news release. 'For nearly two decades, we've been focused on a bold vision, one that many thought was out of reach. Our scientists, engineers, clinical advisors and partners have poured their hearts into this innovation. Today we celebrate this success, but we know the work is far from done. There are millions of people waiting for us to get the Ocumetics Lens to market, and we are more driven than ever to bring this solution to the world.' 'The Ocumetics accommodating intraocular lens has the potential to reshape the global standard of care first for cataract, and eventually, presbyopia patients,' Burns added. 'This milestone reinforces Ocumetics' position as a leader in the next generation of ophthalmic innovation. With aging populations around the globe demanding better vision solutions, the potential impact of the Ocumetics Lens is profound.' About Ocumetics Technology Ocumetics is a Canadian research and product development company focused on vision-correction solutions, including an intraocular lens that fits within the eye's natural lens compartment. Ocumetics stock (TSXV:OTC) is up by 75 per cent trading at C$1.75 as of 10:51 am ET. The stock has added 464.52 per cent year-over-year. Join the discussion: Find out what investors are saying about this Canadian healthcare technology stock on the Ocumetics Technology Corp. Bullboard, and make sure to explore the rest of Stockhouse's stock forums and message boards. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
CBC
4 hours ago
- CBC
Risk of radioactive contamination prompts Walmart frozen shrimp recall in U.S.
Walmart has recalled frozen, raw shrimp sold in 13 U.S. states because federal health officials say it could have potential radioactive contamination. The U.S. Food and Drug Administration asked Walmart to pull three lots of Great Value brand frozen shrimp from stores after federal officials detected Cesium-137, a radioactive isotope, in shipping containers and a sample of breaded shrimp imported from Indonesia. The products could pose a "potential health concern" for people exposed to low levels of Cesium-137 over time, FDA officials said. "If you have recently purchased raw frozen shrimp from Walmart that matches this description, throw it away," FDA officials said in a statement. The risk from the recalled shrimp is "quite low," said Donald Schaffner, a food safety expert at Rutgers University. Cesium-137 is a byproduct of nuclear reactions, including nuclear bombs, testing, reactor operations and accidents. It's widespread around the world, with trace amounts found in the environment, including soil, food and air. The level detected in the frozen breaded shrimp was far lower than FDA intervention levels. However, the agency said that avoiding potentially contaminated products could reduce exposure to low-level radiation that could lead to health problems over time. The FDA is investigating reports of Cesium-137 contamination in shipping containers and products processed by P.T. Bahari Makmur Sejati, doing business as BMS Foods of Indonesia. U.S. Customs and Border Protection officials alerted FDA that they found Cesium-137 in shipping containers sent to U.S. ports in Los Angeles, Houston, Miami and Savannah, Georgia. FDA officials collected several product samples and detected contamination in one sample of frozen breaded shrimp. The shipping containers and products were denied entry into the U.S. However, the FDA then learned that Walmart had received potentially affected products imported after the first detection, from shipments that did not trigger contamination alerts. Walmart immediately recalled the products, a company spokesperson said. They include Great Value brand frozen raw shrimp with lot codes 8005540-1, 8005538-1 and 8005539-1, all with best-by dates of March 15, 2027. The shrimp was sold in Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Oklahoma, Pennsylvania, Texas and West Virginia. Consumers should discard the products or return them to any Walmart store for refund.
